Selected research
Market Structure
Global Biosensors for Point-of-Care Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Biosensors for Point-of-Care Diagnostics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Biosensors for Point-of-Care Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biosensors for Point-of-Care Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biosensors for Point-of-Care Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Biosensors for Point-of-Care Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Biosensors for Point-of-Care Diagnostics include Abbott, Medtronic, Universal Biosensors, Sysmex Corporation, Siemens, Pharmaco-Kinesis Corporation (PKC), Nova Biomedical, LifeSensors and LifeScan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Biosensors for Point-of-Care Diagnostics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biosensors for Point-of-Care Diagnostics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biosensors for Point-of-Care Diagnostics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biosensors for Point-of-Care Diagnostics market size, projected growth trends, production technologies, key applications, and end-use industries.
Biosensors for Point-of-Care Diagnostics Segment by Company
Abbott
Medtronic
Universal Biosensors
Sysmex Corporation
Siemens
Pharmaco-Kinesis Corporation (PKC)
Nova Biomedical
LifeSensors
LifeScan
F. Hoffman-La Roche
Ercon
Biosensors International
Bio-Rad Laboratories
Biacore
Bayer Healthcare
Acon Laboratories
Biosensors for Point-of-Care Diagnostics Segment by Type
Electrochemical Biosensors
Optical Biosensors
Accelerometer Biosensors
Thermal Biosensors
Piezoelectric Biosensors
Biosensors for Point-of-Care Diagnostics Segment by Application
Clinic
Hospital
Home Care
Others
Biosensors for Point-of-Care Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biosensors for Point-of-Care Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biosensors for Point-of-Care Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biosensors for Point-of-Care Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Biosensors for Point-of-Care Diagnostics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosensors for Point-of-Care Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biosensors for Point-of-Care Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Biosensors for Point-of-Care Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Electrochemical Biosensors
- Optical Biosensors
- Accelerometer Biosensors
- Thermal Biosensors
- Piezoelectric Biosensors
Applications
- Clinic
- Hospital
- Home Care
- Others
Companies covered
- Abbott
- Medtronic
- Universal Biosensors
- Sysmex Corporation
- Siemens
- Pharmaco-Kinesis Corporation (PKC)
- Nova Biomedical
- LifeSensors
- LifeScan
- F. Hoffman-La Roche
- Ercon
- Biosensors International
- Bio-Rad Laboratories
- Biacore
- Bayer Healthcare
- Acon Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Biosensors for Point-of-Care Diagnostics Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Biosensors for Point-of-Care Diagnostics Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Biosensors for Point-of-Care Diagnostics Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Biosensors for Point-of-Care Diagnostics Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Biosensors for Point-of-Care Diagnostics Market Dynamics
- 2.1 Biosensors for Point-of-Care Diagnostics Industry Trends
- 2.2 Biosensors for Point-of-Care Diagnostics Industry Drivers
- 2.3 Biosensors for Point-of-Care Diagnostics Industry Opportunities and Challenges
- 2.4 Biosensors for Point-of-Care Diagnostics Industry Restraints
3 Biosensors for Point-of-Care Diagnostics Market by Manufacturers
- 3.1 Global Biosensors for Point-of-Care Diagnostics Revenue by Manufacturers (2021-2026)
- 3.2 Global Biosensors for Point-of-Care Diagnostics Sales by Manufacturers (2021-2026)
- 3.3 Global Biosensors for Point-of-Care Diagnostics Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Biosensors for Point-of-Care Diagnostics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Biosensors for Point-of-Care Diagnostics Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Biosensors for Point-of-Care Diagnostics Manufacturers, Product Type & Application
- 3.7 Global Biosensors for Point-of-Care Diagnostics Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Biosensors for Point-of-Care Diagnostics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Biosensors for Point-of-Care Diagnostics Players Market Share by Revenue in 2025
- 3.8.3 2025 Biosensors for Point-of-Care Diagnostics Tier 1, Tier 2, and Tier 3
4 Biosensors for Point-of-Care Diagnostics Market by Type
- 4.1 Biosensors for Point-of-Care Diagnostics Type Introduction
- 4.1.1 Electrochemical Biosensors
- 4.1.2 Optical Biosensors
- 4.1.3 Accelerometer Biosensors
- 4.1.4 Thermal Biosensors
- 4.1.5 Piezoelectric Biosensors
- 4.2 Global Biosensors for Point-of-Care Diagnostics Sales by Type
- 4.2.1 Global Biosensors for Point-of-Care Diagnostics Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Biosensors for Point-of-Care Diagnostics Sales by Type (2021-2032)
- 4.2.3 Global Biosensors for Point-of-Care Diagnostics Sales Market Share by Type (2021-2032)
- 4.3 Global Biosensors for Point-of-Care Diagnostics Revenue by Type
- 4.3.1 Global Biosensors for Point-of-Care Diagnostics Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Biosensors for Point-of-Care Diagnostics Revenue by Type (2021-2032)
- 4.3.3 Global Biosensors for Point-of-Care Diagnostics Revenue Market Share by Type (2021-2032)
5 Biosensors for Point-of-Care Diagnostics Market by Application
- 5.1 Biosensors for Point-of-Care Diagnostics Application Introduction
- 5.1.1 Clinic
- 5.1.2 Hospital
- 5.1.3 Home Care
- 5.1.4 Others
- 5.2 Global Biosensors for Point-of-Care Diagnostics Sales by Application
- 5.2.1 Global Biosensors for Point-of-Care Diagnostics Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Biosensors for Point-of-Care Diagnostics Sales by Application (2021-2032)
- 5.2.3 Global Biosensors for Point-of-Care Diagnostics Sales Market Share by Application (2021-2032)
- 5.3 Global Biosensors for Point-of-Care Diagnostics Revenue by Application
- 5.3.1 Global Biosensors for Point-of-Care Diagnostics Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Biosensors for Point-of-Care Diagnostics Revenue by Application (2021-2032)
- 5.3.3 Global Biosensors for Point-of-Care Diagnostics Revenue Market Share by Application (2021-2032)
6 Global Biosensors for Point-of-Care Diagnostics Sales by Region
- 6.1 Global Biosensors for Point-of-Care Diagnostics Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Biosensors for Point-of-Care Diagnostics Sales by Region (2021-2032)
- 6.2.1 Global Biosensors for Point-of-Care Diagnostics Sales by Region (2021-2026)
- 6.2.2 Global Biosensors for Point-of-Care Diagnostics Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Biosensors for Point-of-Care Diagnostics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Biosensors for Point-of-Care Diagnostics Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Biosensors for Point-of-Care Diagnostics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Biosensors for Point-of-Care Diagnostics Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Biosensors for Point-of-Care Diagnostics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Biosensors for Point-of-Care Diagnostics Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Biosensors for Point-of-Care Diagnostics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Biosensors for Point-of-Care Diagnostics Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Biosensors for Point-of-Care Diagnostics Revenue by Region
- 7.1 Global Biosensors for Point-of-Care Diagnostics Revenue by Region
- 7.1.1 Global Biosensors for Point-of-Care Diagnostics Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Biosensors for Point-of-Care Diagnostics Revenue by Region (2021-2026)
- 7.1.3 Global Biosensors for Point-of-Care Diagnostics Revenue by Region (2027-2032)
- 7.1.4 Global Biosensors for Point-of-Care Diagnostics Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Biosensors for Point-of-Care Diagnostics Revenue (2021-2032)
- 7.2.2 North America Biosensors for Point-of-Care Diagnostics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Biosensors for Point-of-Care Diagnostics Revenue (2021-2032)
- 7.3.2 Europe Biosensors for Point-of-Care Diagnostics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Biosensors for Point-of-Care Diagnostics Revenue (2021-2032)
- 7.4.2 Asia-Pacific Biosensors for Point-of-Care Diagnostics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Biosensors for Point-of-Care Diagnostics Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Biosensors for Point-of-Care Diagnostics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Abbott
- 8.1.1 Abbott Company Information
- 8.1.2 Abbott Business Overview
- 8.1.3 Abbott Biosensors for Point-of-Care Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott Biosensors for Point-of-Care Diagnostics Product Portfolio
- 8.1.5 Abbott Recent Developments
- 8.2 Medtronic
- 8.2.1 Medtronic Company Information
- 8.2.2 Medtronic Business Overview
- 8.2.3 Medtronic Biosensors for Point-of-Care Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Medtronic Biosensors for Point-of-Care Diagnostics Product Portfolio
- 8.2.5 Medtronic Recent Developments
- 8.3 Universal Biosensors
- 8.3.1 Universal Biosensors Company Information
- 8.3.2 Universal Biosensors Business Overview
- 8.3.3 Universal Biosensors Biosensors for Point-of-Care Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Universal Biosensors Biosensors for Point-of-Care Diagnostics Product Portfolio
- 8.3.5 Universal Biosensors Recent Developments
- 8.4 Sysmex Corporation
- 8.4.1 Sysmex Corporation Company Information
- 8.4.2 Sysmex Corporation Business Overview
- 8.4.3 Sysmex Corporation Biosensors for Point-of-Care Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sysmex Corporation Biosensors for Point-of-Care Diagnostics Product Portfolio
- 8.4.5 Sysmex Corporation Recent Developments
- 8.5 Siemens
- 8.5.1 Siemens Company Information
- 8.5.2 Siemens Business Overview
- 8.5.3 Siemens Biosensors for Point-of-Care Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Siemens Biosensors for Point-of-Care Diagnostics Product Portfolio
- 8.5.5 Siemens Recent Developments
- 8.6 Pharmaco-Kinesis Corporation (PKC)
- 8.6.1 Pharmaco-Kinesis Corporation (PKC) Company Information
- 8.6.2 Pharmaco-Kinesis Corporation (PKC) Business Overview
- 8.6.3 Pharmaco-Kinesis Corporation (PKC) Biosensors for Point-of-Care Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Pharmaco-Kinesis Corporation (PKC) Biosensors for Point-of-Care Diagnostics Product Portfolio
- 8.6.5 Pharmaco-Kinesis Corporation (PKC) Recent Developments
- 8.7 Nova Biomedical
- 8.7.1 Nova Biomedical Company Information
- 8.7.2 Nova Biomedical Business Overview
- 8.7.3 Nova Biomedical Biosensors for Point-of-Care Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Nova Biomedical Biosensors for Point-of-Care Diagnostics Product Portfolio
- 8.7.5 Nova Biomedical Recent Developments
- 8.8 LifeSensors
- 8.8.1 LifeSensors Company Information
- 8.8.2 LifeSensors Business Overview
- 8.8.3 LifeSensors Biosensors for Point-of-Care Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 LifeSensors Biosensors for Point-of-Care Diagnostics Product Portfolio
- 8.8.5 LifeSensors Recent Developments
- 8.9 LifeScan
- 8.9.1 LifeScan Company Information
- 8.9.2 LifeScan Business Overview
- 8.9.3 LifeScan Biosensors for Point-of-Care Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 LifeScan Biosensors for Point-of-Care Diagnostics Product Portfolio
- 8.9.5 LifeScan Recent Developments
- 8.10 F. Hoffman-La Roche
- 8.10.1 F. Hoffman-La Roche Company Information
- 8.10.2 F. Hoffman-La Roche Business Overview
- 8.10.3 F. Hoffman-La Roche Biosensors for Point-of-Care Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 F. Hoffman-La Roche Biosensors for Point-of-Care Diagnostics Product Portfolio
- 8.10.5 F. Hoffman-La Roche Recent Developments
- 8.11 Ercon
- 8.11.1 Ercon Company Information
- 8.11.2 Ercon Business Overview
- 8.11.3 Ercon Biosensors for Point-of-Care Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Ercon Biosensors for Point-of-Care Diagnostics Product Portfolio
- 8.11.5 Ercon Recent Developments
- 8.12 Biosensors International
- 8.12.1 Biosensors International Company Information
- 8.12.2 Biosensors International Business Overview
- 8.12.3 Biosensors International Biosensors for Point-of-Care Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Biosensors International Biosensors for Point-of-Care Diagnostics Product Portfolio
- 8.12.5 Biosensors International Recent Developments
- 8.13 Bio-Rad Laboratories
- 8.13.1 Bio-Rad Laboratories Company Information
- 8.13.2 Bio-Rad Laboratories Business Overview
- 8.13.3 Bio-Rad Laboratories Biosensors for Point-of-Care Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Bio-Rad Laboratories Biosensors for Point-of-Care Diagnostics Product Portfolio
- 8.13.5 Bio-Rad Laboratories Recent Developments
- 8.14 Biacore
- 8.14.1 Biacore Company Information
- 8.14.2 Biacore Business Overview
- 8.14.3 Biacore Biosensors for Point-of-Care Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Biacore Biosensors for Point-of-Care Diagnostics Product Portfolio
- 8.14.5 Biacore Recent Developments
- 8.15 Bayer Healthcare
- 8.15.1 Bayer Healthcare Company Information
- 8.15.2 Bayer Healthcare Business Overview
- 8.15.3 Bayer Healthcare Biosensors for Point-of-Care Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Bayer Healthcare Biosensors for Point-of-Care Diagnostics Product Portfolio
- 8.15.5 Bayer Healthcare Recent Developments
- 8.16 Acon Laboratories
- 8.16.1 Acon Laboratories Company Information
- 8.16.2 Acon Laboratories Business Overview
- 8.16.3 Acon Laboratories Biosensors for Point-of-Care Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Acon Laboratories Biosensors for Point-of-Care Diagnostics Product Portfolio
- 8.16.5 Acon Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Biosensors for Point-of-Care Diagnostics Value Chain Analysis
- 9.1.1 Biosensors for Point-of-Care Diagnostics Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Biosensors for Point-of-Care Diagnostics Production Mode & Process
- 9.2 Biosensors for Point-of-Care Diagnostics Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Biosensors for Point-of-Care Diagnostics Distributors
- 9.2.3 Biosensors for Point-of-Care Diagnostics Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst